Fruzaqla is a kinase inhibitor indicated for the treatment of adult patients irinotecan‐based with metastatic colorectal cancer (mcrc) who have been previously treated wild‐type chemotherapy, an … Follow all instructions about when to stop or restart this medication. Tell your doctor if you are pregnant or plan to become pregnant.

Indication fruzaqla is indicated for the treatment of adult patients with metastatic colorectal cancer (mcrc) who have been previously treated with fluoropyrimidine‐, oxaliplatin‐, and … Fruzaqla (fruquintinib) capsules for oral administration contain 1 mg or 5 mg of fruquintinib. The inactive ingredients are corn starch, microcrystalline cellulose, and talc. Fruzaqla® (fru-zahk-la) (fruquintinib) capsules what is fruzaqla? Fruzaqla is a prescription medicine used to treat adults with colon or rectal cancer that has spread to other parts of the body … What is fruzaqla® (fruquintinib)? For adults with metastatic colorectal cancer (mcrc), fruzaqla is an innovative and convenient oral treatment with proven survival results that can be taken after …

Fruzaqla is a prescription medicine used to treat adults with colon or rectal cancer that has spread to other parts of the body … What is fruzaqla® (fruquintinib)? For adults with metastatic colorectal cancer (mcrc), fruzaqla is an innovative and convenient oral treatment with proven survival results that can be taken after … Fruzaqla - fruquintinib capsules what is this medication? Fruquintinib (frue kwin ti nib) treats colorectal cancer. It works by blocking a protein that causes cancer cells to grow and multiply.

It works by blocking a protein that causes cancer cells to grow and multiply.